An experimental drug has shown great promise in limiting the damage that a heart attack can inflict on the heart. It targets a protein that plays a central role in the death of heart muscle cells.
Tests on mice have revealed that the drug could markedly reduce heart injury from a heart attack.
The small-molecule drug blocks the protein MAP4K4, which relays the oxidative stress signals that cause the death of heart muscle cells and damage to tissue.
“There are no existing therapies,” says lead investigator Dr. Michael D. Schneider, from Imperial College London in the United Kingdom, “that directly address the problem of muscle cell death, and this would be a revolution in the treatment of heart attacks.”
Source: Medical News TodayRead More